Influence of long-distance trail running on blood hemostasis at the World Mountain Trail Running Championship 2023-a pilot study

长距离越野跑对2023年世界山地越野锦标赛血液止血的影响——一项初步研究

阅读:1

Abstract

BACKGROUND: Severe exercise performed over longer duration can involve multiple prothrombotic alterations in blood coagulation markers. Standard coagulation tests are not robust in identifying hyper- or hypocoagulability due to indirect determination of changes in hemostasis and fibrinolysis. Conversely, viscoelastic tests might do so. OBJECTIVES: The aim of this pilot study was to assess the exercise-induced changes in coagulatory and fibrinolytic processes by applying viscoelastic tests in a mountain ultramarathon. Seven elite athletes participating in the World Mountain and Trailrunning Championship 2023 were examined. The 86.9 km track involved 6500 m of climbing and 6920 m of descent. METHODS: Venous blood samples were taken the day prior to and within 3 hours following the competition. Plasma coagulation tests and whole blood viscoelastic coagulation tests (ClotPro) were used to assess changes in hemostasis. RESULTS: Plasma coagulation testing revealed prolonged prothrombin time, with correlatively decreased factor (F)V, FVII, and FX activities. As a consequence of increased intrinsic coagulation factor activities (FVIII, FIX, FXI, and FXII) and von Willebrand factor, activated partial thromboplastin time was shortened. In addition, plasminogen decreased, whereas α2-antiplasmin and D-dimer showed significant elevations. Maximal lysis, examined by viscoelastometric tests, was observed to be slightly diminished postrace, whereas fibrin polymerization increased. CONCLUSION: The trail-long race generated substantial alterations in coagulation that were linked to a higher inflammatory state, with characteristic increases in FVIII, von Willebrand factor, and fibrinogen levels. Viscoelastic coagulation monitoring used in our study was able to reflect the summation of pro- and anticoagulants, as well as pro- and antifibrinolytic changes, in hemostasis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。